No Detail Found!

Diagnostic Accuracy of Glypican-3 in Differentiating Hepatocellular Carcinoma from Metastatic Liver Tumours.

Author(s)
Sadia Majeed University College of Medicine, University of Lahore, Lahore, Pakistan
Sajid Mushtaq Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH&RC), Lahore, Pakistan
Muhammad Azam Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH&RC), Lahore, Pakistan
Noreen Akhtar Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH&RC), Lahore, Pakistan
Mudassar Hussain Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH&RC), Lahore, Pakistan
Asif Loya Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH&RC), Lahore, Pakistan
Abstract
Objective: To determine the diagnostic accuracy of Glypican-3 in differentiating hepatocellular carcinoma from metastatic liver tumours while taking histopathology as the gold standard. Methods: The cross-sectional study was conducted at Shaukat Khanum Memorial Cancer Hospital, Lahore, Pakistan, from January 1 to June 30, 2016, and comprised cases of malignant liver tumours. Samples were collected from the pathology department. Glypican-3was applied on them. Tumours were classified as positive when they showed >5% positivity and negative when showing <5% positivity. Frequencies and percentages of cases showing GPC3 positivity and negativity along with frequency and percentages of hepatocellular carcinoma and metastatic tumours were calculated. Results: Of the 240 patients, 143(59.58%) were males and 97 (40.42%) were females. Overall mean age was 54.65 ± 13.46 years. On histopathology, 134 cases were hepatocellular carcinoma (55.83%) and 106 (44. 17%) cases turned out to be metastatic carcinoma. Glypican-3staining was positive in 116 (48.33%) cases and negative in 124(51.67%). Sensitivity was 82%, Specificity 94.33%, positive predictive value 94.82% and negative predictive value 80.64%. Diagnostic accuracy was 87.5%. Conclusion: Glypican-3 was found to be a highly sensitive and specific Immunohistochemistry stain distinguishing hepatocellular carcinoma from the clear majority of metastatic carcinomas of the liver.
Publication Details
Page(s) 1029-1031
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 68, Issue: 7, Year: 2018

Request the full text from PASTIC

References
VenookAP,PapandreouC,FuruseJ,de GuevaraLL, 2010.The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective,Oncologist 15 5 -13
.Hepatitis C virus to hepatocellular carcinoma,Infect Agent 4 -
Cancer, 2012., 7 2 -
2005.Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma,J Hepatol 42 27 -34
ChoiBI., 2004.The current status of imaging diagnosis of hepatocellular carcinoma,Liver Transpl 10 S20 -5
2009.Hepatocellular carcinoma (HCC) and diagnostic significance of Afetoprotein (AFP),J Ayub Med Coll Abbottabad 21 72 -5
2003.Immunoreactivity of Hep Par 1 in hepatic and extrahepatictumours and its correlation with albumin in situ hybridization in hepatocellular carcinoma,Am J ClinPathol 119 361 -6
2004.Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples,Am J ClinPathol 122 721 -7
2008.Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions,Arch Pathol Lab Med 132 1723 -8
ShafizadehN,LindaDF,KkarS. Utility, 2008.and limitations of Glypican -3 expression for the diagnosis of hepatocellular carcinoma at both ends of differentiation spectrum,Mod Pathol 21 1011 -8
JHepatol, 2007.The oncofetal gene glypican 3 is regulated in the postnatal liver by zinc fingers and homeoboxes 2 and in the regenerating liver by alpha-fetoprotein regular 2, 46 1541 -7
ZaakookM,AyoubM,SinnaEA,El-Sheikh S, 2013.Role of glypican-3 immunocytochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver utilizing fine needle aspiration cytology,J Egypt Natl Canc Inst 25 173 -80
2010.Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy,J Clin Pathol 63 599 -603
LigatoS,MandichD,CartunRW, 2008.Utility of glypican-3 in differentiating hepatocellular carcinoma from other primary and metastatic lesions in FNA of the liver: an immunocytochemical study,Mod Pathol 21 626 -31
0

Citations

0

Downloads

100

Views